WallStreetZenWallStreetZen

NASDAQ: OTLK
Outlook Therapeutics Inc Stock Ownership - Who owns Outlook Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Outlook Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Yezan Munther HaddadinDirector2024-03-281,881$11.82
$22.23kBuy
Jeff EvansonCHIEF COMMERCIAL OFFICER2024-03-0762,484$0.42
$26.24kBuy

1 of 1

OTLK insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OTLK insiders and whales buy or sell their stock.

OTLK Shareholders

What type of owners hold Outlook Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ghiath M. Sukhtian582.92%75,855,278$628.84MInsider
Faisal Ghiath Sukhtian429.46%55,884,786$463.28MInsider
Biolexis Pte Ltd195.52%25,443,159$210.92MInsider
Arun Kumar Pillai176.61%22,982,529$190.53MInsider
Blackrock Inc79.66%10,366,285$85.94MInstitution
Pankaj Mohan63.67%8,285,115$68.68MInsider
Vanguard Group Inc50.41%6,560,400$54.39MInstitution
Geode Capital Management LLC22.83%2,970,346$24.62MInstitution
State Street Corp21.72%2,826,493$23.43MInstitution
Syntone Ventures LLC13.11%1,705,438$14.14MInsider

1 of 3

OTLK vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OTLK13.26%86.74%Net BuyingNet Buying
IMUX16.47%17.18%Net BuyingNet Buying
ELYM60.80%23.57%Net Buying
SEER54.70%45.30%Net BuyingNet Selling
LIFE60.86%22.55%Net BuyingNet Selling
View Top Biotech Stocks

Outlook Therapeutics Stock Ownership FAQ

Who owns Outlook Therapeutics?

Outlook Therapeutics (NASDAQ: OTLK) is owned by 226.90% institutional shareholders, 1,483.83% Outlook Therapeutics insiders, and 0.00% retail investors. Ghiath M. Sukhtian is the largest individual Outlook Therapeutics shareholder, owning 75.86M shares representing 582.92% of the company. Ghiath M. Sukhtian's Outlook Therapeutics shares are currently valued at $619.74M.

If you're new to stock investing, here's how to buy Outlook Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.